June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Idiopathic Intermediate Uveitis: A 25-year study of visual prognosis
Author Affiliations & Notes
  • William Tucker
    Ophthalmology Dept, Guys & St Thomas' NHS Foundation Trust, London, United Kingdom
  • Elizabeth Graham
    Ophthalmology Dept, Guys & St Thomas' NHS Foundation Trust, London, United Kingdom
  • Philip Murray
    School of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom
  • Miles Stanford
    Ophthalmology Dept, Guys & St Thomas' NHS Foundation Trust, London, United Kingdom
  • Footnotes
    Commercial Relationships William Tucker, None; Elizabeth Graham, Santen (C); Philip Murray, None; Miles Stanford, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 355. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      William Tucker, Elizabeth Graham, Philip Murray, Miles Stanford; Idiopathic Intermediate Uveitis: A 25-year study of visual prognosis. Invest. Ophthalmol. Vis. Sci. 2013;54(15):355.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Idiopathic Intermediate Uveitis (IIU) is a chronic intraocular inflammatory disorder, which affects over 10% of the uveitis population. This study aims to identify the long-term outcomes and complication rates for patients with IIU.

Methods: A retrospective review of 100 patients from two regional uveitis centres with a follow-up of between 5 and 25 years. The main outcome measure was maintenance of best-corrected visual acuity (BCVA) at 20/40 or better.

Results: The average age at onset of IIU was 38 years (range 4 - 73 years) and 41% were male. Mean follow-up time was 12 years with 26 out of 100 patients having more than 20 years follow-up. Baseline BCVA was recorded after 3 months of treatment with 89% at 20/40 or better, this level of BCVA was maintained over the follow-up period with 82% at 20/40 or better after 5, 10 and 15 years. BCVA was 6/12 or better in 85% at 20 years and 80% after 25 years of follow-up. There was a significant correlation between baseline BCVA and the BCVA at final follow-up with 84% maintaining visual acuity of 20/40 or better (Spearman’s rank correlation coefficient = 0.502 (p<0.0001)).

Conclusions: The visual prognosis for patients with IIU is good with 84% maintaining vision better than or equal to 20/40. Patients who present with visual acuity at this level can be reassured they have a reasonable chance of keeping it long term.

Keywords: 745 uvea • 462 clinical (human) or epidemiologic studies: outcomes/complications • 461 clinical (human) or epidemiologic studies: natural history  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×